03 Jun 2013
The European Medicines Agency (EMA) has published the latest news from its Committee for Medicinal Products for Human Use, including updates on Somatropin Biopartners for endogenous growth hormone deficiency, its review of new safety data on insulin glargine, an application to modify the approved use of Lysodren (mitotane) and a Q&A on withdrawal of the marketing authorisation application for
Belviq (lorcaserin).
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024